Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells
Lists
Only you see this
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a serious threat to human health and lacks an effective treatment. There is an urgent need for both real-time tracking and precise treatment of the SARS-CoV-2-infected cells to mitigate and ultimately prevent viral transmission. However, selective triggering and tracking of the therapeutic process in the infected cells remains challenging. Here, we report a main protease (M<sup>pro</sup>)-responsive, mitochondrial-targeting, and modular-peptide-conjugated probe (PSGMR) for selective imaging and inhibition of SARS-CoV-2-infected cells via enzyme-instructed self-assembly and aggregation-induced emission (AIE) effect. The amphiphilic PSGMR was constructed with tunable structure and responsive efficiency and validated with recombinant proteins, cells transfected with M<sup>pro</sup> plasmid or infected by SARS-CoV-2, and a M<sup>pro</sup> inhibitor. By rational construction of AIE luminogen (AIEgen) with modular peptides and M<sup>pro</sup>, we verified that the cleavage of PSGMR yielded gradual aggregation with bright fluorescence and enhanced cytotoxicity to induce mitochondrial interference of the infected cells. This strategy may have value for selective detection and treatment of SARS-CoV-2-infected cells.
BibTeX
@inproceedings{cheng2022protease,
author = {Yong Cheng and Alex E. Clark and Jiajing Zhou and Tengyu He and Yi Li and Raina M. Borum and Matthew N. Creyer and Ming Xu and Zhicheng Jin and Jingcheng Zhou and Wonjun Yim and Zhuohong Wu and Pavla Fajtová and Anthony J. O’Donoghue and Aaron F. Carlin and Jesse V. Jokerst},
title = {{Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells}},
booktitle = {ACS},
year = {2022},
doi = {10.1021/acsnano.2c03219},
}Loading related content...